Featured Jobs
|
Principal (Retrospective Outcomes Research) IMS Health |
|
|
Analysts and Consultants, Real-World Evidence Solutions & HEOR IMS Health |
|
|
Research Analyst Humana |
|
|
|
News
- Which HE-Artist designed baby doll clothes as a child and loves the sound of twittering birds?
- Do payers share enough data with ACO partners?
- Patients provide real world perspective to FDA
- Need a Simple Guide to Selecting PRO Measures?
- Do pharma companies need a dedicated platform for key account management?
- Overview of the Cancer Pain Market
- Global biosimilar market will grow to $2.44bn this year!
- 15 Game-Changing Case Studies of Where EBM has benefitted Patients
- The Bioinformatics Market is Poised for Growth - What do we do with it?
- Do payers share enough data with ACO partners?
- Health Care Costs from Birth to Death
- Do pharma companies need a dedicated platform for key account management?
- Overview of the Cancer Pain Market, Incidence, Treatment and Forecast
- Medicare Provider Charge Data
- Let Us Fear the Price of "Cutting-Edge" Drugs!
- Market Access, where do you see the industry in 12 months time?
- Specialty Medications will make up 40 percent of all pharmacy benefit costs by 2020!
- Will GSK share late-phase research data on outcomes and costs too?
- Top 5 Most Popular Pharma Informatics Stories of 2012
- Is This What Your Team Needs? The World's Shortest Marketing Plan
- Conflict of Interest? Former NICE chair joins board of biotech
- Interview with CEO, Yin Ho, of Context Matters
- Does Cancer Increase Bankruptcy Risk?
- Contracting for Quality in the NHS is Topic of OHE's 20th Annual Lecture
- ISPOR's second NEW book!
- HealthEconomics.Com Announces HE-Xpo-a New Virtual Trade Show Devoted to Healthcare Value and Market
- SPAARx Launch a Big Success at Armada Summit
- Sanofi partners with PatientsLikeMe to promote clinical trials
- The Rise of Health Outcome Liaison Teams
- White Paper: How do users of CERs want to view new information?
- New ISPOR Book Released
- The future of medicaid drug reimbursement
- Archived Webcast from Pharmaceutical Executive Now Available
- Pharma must provide convincing evidence of drug value
- NASP Launches the Specialty Pharmacy Education Center
- IMS Expanding Capabilities with Recent Acquisitions
- Drug Development Communications: Does the right hand know what the left is doing?
- Value in Health Regional Issues: Burden of Disease Studies in the Asia-Pacific Region
- PRMA President Responds With Letter to the Editor of NYT
- Misunderstanding the Oregon Medicaid Study
- Economist Finds US Health Care as Source of Humor
- NASP Bringing Positive Changes to Specialty Rx Market
- OHE’s Adrian Towse is ISPOR President-Elect for 2013-14
- American Health Care as a Source of Humor?
- NICE Presentation: Effectively including patients and the public in HTA decision making
- AMNOG Goes Retro?
- Would Drug Makers Rather Implement Subsidies or Incur Weakened Patent Protection in Chinese Market?
- Prescription Costs Driven Up by Specialty Drugs
- What do Mandela, The Eagles, & Lincoln have in common? Ask Marcus Wilson, President of HealthCore
- When was the last time you let your creativity run wild?
- Specialty Pharmacy Certification Board Establishes Code of Conduct, Eligibility Requirements, & Fees
- Does Enrolling in Medicaid Improve Health?
- Amgen Reaches $11 Million Medicaid Settlement
- Would price discounting be smart business for pharma?
- Could PCORI Research Network 'Normalize' Clinical Trial Data?
- Download Shire’s Rare Disease Impact Report: Insights from patients and the medical community
- New OHE Research: Valuing Orphan Medicines Using Multi-Criteria Decision Analysis
- What's the One word that you most associate with HealthEconomics.Com?
- Effective Email Strategies for the HEOR Audience. Lessons from HealthEconomics.Com.
- What happens when you pay two monkeys unequally?
- European Medicines Agency told not to disclose data
- Video: PCORI Roundtable - Building a National Data Infrastructure to Advance CER
- What Do Scientific Studies Show?
- Is the ACA responsible for bending the health care cost curve?
- Models Do Drive Decision Making, But Do They Take You Where You Want to Go?
- What methods can specialty drug manufacturers employ to optimize consolidation?
- IMS Health Advances Cloud-Based Social Media Analytics
- PCORI to Invest $68 Million to Develop a National Patient-Centered Clinical Research Network
- Thomas Blissenbach, RPh, MS Appointed to NASP Board of Directors
- Consolidated Health Economic Evaluation Reporting Standards (CHEERS) - Explanation and Elaboration
- New tHEORetically Speaking Blog: Hospital Profits Higher When Surgical Patients Develop Complications
- PCORI Unveils New Clinical Research Network
- Is Real World Evidence Gaining Traction Among Physicians?
- Snapshot of cancer research reveals lack of rigor & robustness
- Is mHealth a 'perfect fit' for PCORI's patient-powered research networks?
- Is PCORI in the Hot Seat?
- Video: The Future of Publications From a Patient-Centered Outcomes Perspective
- Meet HE-Artist John Mackowiak - Old House 'Sculptor' & Journal Editor
- OHE's Towse on Quality Standards in the 'New' English NHS
- Pharma Whinges About Government Drug Sales Force
- How does cost-effectiveness influence NICE decisions?
- PCORI Names Bryan Luce Chief Science Officer
- Pharmaceutical Pricing and Health Outcomes Top Trending News This Week from HealthEconomics.Com
- Doctors Banding Together to Bring Down Cancer Rx Prices
- CVS employees face $600 fine unless they disclose their weight
- Download the Specialty Pharmacy Selection Guide
- Patient-Centered Outcomes the Focus of ISPOR New Orleans
- What is technology's role in enhancing & expanding the medical information teams' capabilities?
- What's the most effective way to use real world data?
- Prices won't come down without transparency
- Cost vs Benefits of Controlling Messaging in Pharma
- Will increasing prices of some drugs in Spain put citizens purchasing power & health at risk?
- CROs Not Feeling Impact of Clinical Trial Downturn, Analyst Says
- Has Excel Contributed to the Proliferation of Bad Math?
- Results from Latest Express Scripts Research on Worker's Comp Rx Spend
- Valuing Co-Dependent Medical Technologies: Improving Methods and Processes
- What Should You Expect When VBP Launches in UK?
- Launching NOW: HealthEconomics.Com Business Directory for HEOR and Market Access Community
- Meet Our Latest HE-Artist: Ken O'Day - Triathete/Duathlete & Director HEOR
- Roche faces double rejection for Avastin
- Why hasn't adaptive trial design taken off?
- NEW tHEORetically Speaking Blog: The Problem with Preventive Medicine
- New Open-access Patient Registry
- Say GRACE! Principles for Observational Studies
- Free HIPAA Compliant Text Messaging for Healthcare
- Can government austerity affect health outcomes?
- What are the challenges of performance-based risk sharing in health care?
- YouTube: Introducing the HealthEconomics.Com Showcase
- What are the benefits and limitations of the many sources of data now available?
- Lilly says Social Media Allows “Big Companies to Act Small Again”
- Switzerland and pharma forge pricing and access deal
- UnitedHealth teams with providers to evaluate medical devices
- NEW tHEORetically Speaking Blog: The Affordable Care Act: Perfect? Hardly.
- How is Pharma Addressing Global Pricing Pressures & Challenges?
- Slideshare Presentation: Evidence Based Medicine Applications
- What will drugmakers need to do to gain market access for cancer drugs in China?
- What 10 products are expected to be industry’s largest growth drivers through to 2017?
- What's happening in the unfolding biosimilar landscape in Latin America?
- New tHEORetically Speaking Blog: Three Things You Need To Know About Personalized Medicine
- NASP Nomination & Paper Submissions
- What are the Top 4 strategies used by adults to reduce prescription drug costs?
- PatientsLikeMe Developing Platform To Validate PROs
- A Mobile App for Crowdsourcing Vaccine Refusal Data: A Model for Improving Drug Adherence
- How is Aetna using patient data to prevent diabetes & heart attacks?
- NASP Announces First Executive Director
- Who was top influencer at NASP Conference?
- New Challenges/Functions ahead for NICE
- Meet Amanda Justice, the latest HE-Artist from HealthEconomics.Com
- AMNOG Interviews in Phama Times
- New, Bottom-Up Model for Forecasting UK Medicines Expenditure
- Who are these guys? Why the PCORI Picks Matter.
- What will be the impact of Walgreens/Alliance Boots/AmerisourceBergen Deal?
- NPC's Dr. Dubois Talks ACO Expectations at AMCP Meeting
- What is the value of big data in health care?
- HealthEconomics.Com Rated Top Influencer at AMCP 25th Annual Meeting
- This is what it REALLY means to "focus on the patient"
- Orphan Drug Prices Under Siege in Austerity-Minded Europe
- Call for Abstracts for Special Supplement to the Journal of General Internal Medicine
- Asia and the Medical Affairs Function
- What is the difference between compounding and specialty pharmacy?
- New Specialty Pharmacy Issue: Dispensing Excellence
- AMCP Revises Formulary Document to Reflect New Recommendations for Specialty Pharmaceuticals
- AMCP Welcomes New Members to Board of Trustees
- AMCP Unveils New Name for Foundation
- So What Are Payers Doing About ICD-10?
- Who are the Top 10 Pharma Companies in 2017?
- What do physicians think about health reform and the future of medicine?
- Really? Man Jumps From Building To Escape A Clinical Trial
- Who will win the 'Battle of the Biosimilars'?
- Download the Specialty Pharmacy Selection Guide
- Specialty Drug Use and Costs on the Rise
- Device Trends to Watch in 2013
- Is that what you think evidence-based medicine is?
- Why are wealthy nations not doing more to drive down medicine costs?
- CHEERS to better reporting and health decisions!
- 2013 Review - Economics of the UK Market for Medicines
- Breast Cancer Reimbursement Across the G7
- HealthEconomics.Com’s Pharma Pricing and Reimbursement Stories in This Week’s Newsletter
- HHS will fund 100% of Medicaid expansion for 3 years
- Confounding and Missing Data in Cost-Effectiveness Analysis: Comparing different methods
- This looks useful! CER Collaborative to Highlight Online Decision Making Tool at AMCP Annual Meeting
- PatientsLikeMe Launches New Clinical Trial Search Tool for Patients-Will Help Recruitment
- Archimedes, Inc. Expands Use of Big Data in Healthcare Modeling and Analytics
- New Way to Present Comparative Effectiveness Data Using Forest Plots. Does This Communicate?
- Call for Papers! Journal of HEOR
- Biosimilar developers turning to emerging markets
- UK's NICE Central to New Drug Pricing System
- Want to improve Payer/Pharma partnerships?
- NICE to have primary role in UK's VBP
- The Usual Suspects Still Lead Specialty Pharma Trend
- Why Won't Price Transparency Bring Down Health Care Spending?
- tHEORetically Speaking Blog: Effective Email Strategies for the HEOR Audience – Part 2 of 3
- OHE comments on revised draft of NHS competition regulations
- Should taxpayers enjoy lower drug prices if federal money backed development?
- HealthEconomics.Com Presents at Center for Entrepreneurial Development, Presbyterian College
- GSK boss says the high cost of research R&D a myth
- What is the value of medical research?
- Archived webinar: Healthcare Administrative Databases Analysis
- What does the 2011 Health Care Cost and Utilization Report Show?
- Which forward looking companies are improving health outcomes and reducing costs in the US?
- tHEORetically Speaking Blog: Effective Email Strategies for the HEOR Audience – Part 1 of 3
- Are European high-tech companies successfully utilizing data?
- Interview with China’s Ministry of Health on Chinese orphan drug market access
- You’re Invited: April 25th Art Reception for one of our own Health Economists, Agora Gallery, NYC
- Keep up with OHE this week
- What Health Economist wishes they were stranded on a desert island w/just a Swiss Army Knife?
- Archimedes Inc. Renews Annual Marketing Agreement with HealthEconomics.Com
- Why Has Health Information Technology Been Ineffective?
- NICE's Social Value Judgements
- Socially-responsible health economics: What Bill Gates has to say about this:
- How long does it take before results from the average clinical trial are published?
- Pharmas Famous (Infamous) Movie Moments
- Is Utopia on the Horizon with HIT Version 2.0?
- UK Struggles to Implement VBP
- Medtronic great example of how to use social media
- Can Twitter help predict epidemics?
- 2012 Pharmacy Trend Report
- Are you a quick thinker or do you need time to ponder?
- OHE Survey Seeks Reasons for Discontinuation of R&D Projects
- How to Cut Specialty Rx Spend Increases in Half
- Glossary of Specialty Pharma Terms Open to Comment
- Are payers-pharma capable of "fresh thinking"?
- Eisai fires back at German G-BA
- Kaiser Closing Healthcare Gaps with Big Data
- NICE makes U-turn on Novartis' Xolair
- Holistic Real World Data: Multiple Perspectives
- Should drug prices be higher in Europe?
- Learn how to make your data sexy
- Introduction to Evidence-Based Medicine
- PBMs Pitching Specialy Pharma Programs for 2014
- Oh Pharma! Step Away from the MDs. Who Pays Your Bills?
- Is pricing cars similar to pricing healthcare?
- Composite endpoints: Do they just pile on the problems, or simplify life?
- Holistic Real World Data: Multiple Perspectives
- Are drug companies violating anti-trust laws?
- How to Promote to Payers in a Digital World
- Abacus International Expands Annual Partnership With HealthEconomics.Com
- Tracking Drug Trending for 2012
- Can pricing teams rise to the ever-changing challenges?
- Journal editor suggests quarantine of “groundbreaking studies about new treatments”
- Brush-up on & test your knowledge with evidence based medicine flashcards
- AMNOG thought leaders debate
- I want THAT price: Understanding the Rationale Behind International Price Referencing
- Rx spending down, but will it stay there?
- Deep Data is the Next Big Thing
- AstraZeneca Using 'Deep Data' to Inform Stakeholders
- China to establish FDA type agency after safety scandals
- Grace Period Requested by British Pharma Wholesales for VBP
- It's time to drop the words "hurdles" and "barriers" from market access conversations
- Health Economics in Public Decision-Making
- NHS Trust Experimenting with Social Media
- Determining a Strategy with Specialty Pharmacies
- Latest CER Journal Available
- Meet HE-Artist Dr. Mshilla Maghanga
- The FDA weighs in on social media in a warning way
- Market Entry in China
- tHEORetically Speaking Blog - Finding Your Voice: Marketing HEOR Services
- Are you Creative? Artistic? Generally Awesome?
- Specialty Pharmacy Defined
- EBM and how to read research like a Pro: Part 1
- PatientsLikeMe awarded $1.9m grant to create first open research platform
- tHEORetically Speaking Blog: The ABCs of HEOR Social Media
- Read the latest CHE Newsletter
- Germany's IQWiG Pans Pfizer's Xalkori On Study Results, Side Effects
- US Government Expanding Access to Results of Federally Funded Research
- HOLs Key to Bridging Pharma and Managed Care
- Spanish Ministry warns of excessive pricing of cancer drugs
- Why are medical bills killing us?
- Is being readmitted to a hospital a bad outcome?
- tHEORetically Speaking Blog: Challenging a Sacred Cow: The Top-Down Approach to CER
- Introducing our Blog: tHEORetically Speaking, from HealthEconomics.Com
- Announcing HE-Artists: Divina Glah
- Why are GOP Governors Caving on Medicaid Expansion?
- Free download: Definitive collection of health and health care statistics for the UK
- Closing the Quality Gap Series from AHRQ Available
- WellPoint Names 'Outsider' New CEO
- Can a 'joint win' be achieved between NHS and pharma?
- OHE's Review of Plans for Refining PROMs
- Video: Real World Evidence Study Design
- Video: Are payers frustrated with how pharma engages with them?
- Are UK Drug Access Woes Due to "US-Dominated Global Pricing"?
- Read the latest CHE Newsletter
- Teaching EBM and Assessing Competence
- Read the latest issue of HERCnews
- Who is EUnetHTA?
- Grant Opportunity: Infrastructure Development Program in PCORI
- WP243 Thought Leader Compensation: US vs. EU
Spotlight 1 of the Week
Spotlight 2 of the Week
Conference Of The Week
Job Of The Week
Director, Government Policy Systems
The Access Group - Berkeley Heights, New Jersey
Reserve "Job of the Week". Contact us.
Link Of The Week
As the UK launches value-based pricing, Xcenda provides perspective to help market access teams prepare for an environment in which pricing of new branded medications is systematically regulated with broader consideration of “value” as a central principle. Learn how VBP may be implemented.
Reserve "Link of the Week". Contact us.
Survey Of The Week
Need to field an idea or garner support for new product?
Use the HealthEconomics.Com Survey Services.
Reserve "Survey of the Week". Contact us.
Partners
